TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling

作者: Jan C Brase , Marc Johannes , Heiko Mannsperger , Maria Fälth , Jennifer Metzger

DOI: 10.1186/1471-2407-11-507

关键词:

摘要: Background TMPRSS2-ERG gene fusions occur in about 50% of all prostate cancer cases and represent promising markers for molecular subtyping. Although TMPRSS2-ERG fusion seems to be a critical event cancer, the precise functional role development progression is still unclear.

参考文章(35)
Thorsten Schlomm, Markus Graefen, Olaf J C Hellwinkel, Holger Sültmann, Annemarie Poustka, Felix K H Chun, Kerstin A David, Andreas M Luebke, Alexander Haese, Hartwig Huland, Ulrich Sauer, Andreas Erbersdobler, Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. International Journal of Oncology. ,vol. 27, pp. 713- 720 ,(2005) , 10.3892/IJO.27.3.713
Jian Xu, Samy Lamouille, Rik Derynck, TGF-beta-induced epithelial to mesenchymal transition. Cell Research. ,vol. 19, pp. 156- 172 ,(2009) , 10.1038/CR.2009.5
Kirsten D. Mertz, Sunita R. Setlur, Saravana M. Dhanasekaran, Francesca Demichelis, Sven Perner, Scott Tomlins, Joëlle Tchinda, Bharathi Laxman, Robert L. Vessella, Rameen Beroukhimt, Charles Lee, Arul M. Chinnaiyan, Mark A. Rubin, Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model Neoplasia. ,vol. 9, pp. 200- 206 ,(2007) , 10.1593/NEO.07103
Sophia S Cheon, Puviindran Nadesan, Raymond Poon, Benjamin A Alman, Growth factors regulate β-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing Experimental Cell Research. ,vol. 293, pp. 267- 274 ,(2004) , 10.1016/J.YEXCR.2003.09.029
Jianghua Wang, Yi Cai, Chengxi Ren, Michael Ittmann, Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer Cancer Research. ,vol. 66, pp. 8347- 8351 ,(2006) , 10.1158/0008-5472.CAN-06-1966
Anders S. Bjartell, Hikmat Al-Ahmadie, Angel M. Serio, James A. Eastham, Scott E. Eggener, Samson W. Fine, Lene Udby, William L. Gerald, Andrew J. Vickers, Hans Lilja, Victor E. Reuter, Peter T. Scardino, Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clinical Cancer Research. ,vol. 13, pp. 4130- 4138 ,(2007) , 10.1158/1078-0432.CCR-06-3031
Outi R. Saramäki, Anna E. Harjula, Paula M. Martikainen, Robert L. Vessella, Teuvo L.J. Tammela, Tapio Visakorpi, TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis Clinical Cancer Research. ,vol. 14, pp. 3395- 3400 ,(2008) , 10.1158/1078-0432.CCR-07-2051
Kristiina Iljin, Maija Wolf, Henrik Edgren, Santosh Gupta, Sami Kilpinen, Rolf I. Skotheim, Mari Peltola, Frank Smit, Gerald Verhaegh, Jack Schalken, Matthias Nees, Olli Kallioniemi, TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Research. ,vol. 66, pp. 10242- 10246 ,(2006) , 10.1158/0008-5472.CAN-06-1986